Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by New York State Teachers Retirement System

New York State Teachers Retirement System lowered its holdings in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 8.5% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 107,258 shares of the company's stock after selling 9,901 shares during the quarter. New York State Teachers Retirement System owned about 0.09% of Henry Schein worth $7,346,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in the business. Farther Finance Advisors LLC grew its stake in Henry Schein by 237.3% during the 1st quarter. Farther Finance Advisors LLC now owns 2,698 shares of the company's stock worth $186,000 after buying an additional 1,898 shares during the last quarter. Charles Schwab Investment Management Inc. grew its stake in Henry Schein by 1.4% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,191,677 shares of the company's stock worth $82,464,000 after buying an additional 16,616 shares during the last quarter. Oppenheimer Asset Management Inc. grew its stake in Henry Schein by 5.2% during the 1st quarter. Oppenheimer Asset Management Inc. now owns 13,745 shares of the company's stock worth $941,000 after buying an additional 678 shares during the last quarter. State of Alaska Department of Revenue grew its stake in Henry Schein by 2.8% during the 1st quarter. State of Alaska Department of Revenue now owns 14,611 shares of the company's stock worth $1,000,000 after buying an additional 395 shares during the last quarter. Finally, GAMMA Investing LLC grew its stake in Henry Schein by 37.8% during the 1st quarter. GAMMA Investing LLC now owns 3,939 shares of the company's stock worth $270,000 after buying an additional 1,081 shares during the last quarter. Hedge funds and other institutional investors own 96.62% of the company's stock.

Henry Schein Price Performance

Shares of NASDAQ:HSIC traded up $0.19 during trading on Friday, hitting $74.67. 699,008 shares of the stock were exchanged, compared to its average volume of 1,722,429. The company has a fifty day moving average price of $70.70 and a two-hundred day moving average price of $71.19. The company has a market cap of $9.09 billion, a PE ratio of 23.33, a P/E/G ratio of 2.41 and a beta of 0.87. The company has a current ratio of 1.38, a quick ratio of 0.75 and a debt-to-equity ratio of 0.50. Henry Schein, Inc. has a 12-month low of $60.56 and a 12-month high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings results on Monday, May 5th. The company reported $1.15 EPS for the quarter, topping the consensus estimate of $1.11 by $0.04. The business had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a return on equity of 14.87% and a net margin of 3.21%. The company's quarterly revenue was down .1% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.10 EPS. On average, analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current year.

Analysts Set New Price Targets

A number of research firms recently issued reports on HSIC. Barrington Research dropped their price target on Henry Schein from $90.00 to $86.00 and set an "outperform" rating on the stock in a research note on Tuesday, May 6th. Wells Fargo & Company dropped their price objective on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a research note on Tuesday, May 6th. Piper Sandler dropped their price target on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 30th. Finally, Wall Street Zen cut shares of Henry Schein from a "buy" rating to a "hold" rating in a report on Thursday, April 17th. Six equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $79.30.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.